RéMiFaSy: Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Recruiting
CT.gov ID
NCT05547152
Collaborator
University Hospital, Rouen (Other)
100
1
2
35.8
2.8

Study Details

Study Description

Brief Summary

Peripheral facial palsy affects 15 to 40 people per 100,000 inhabitants and induces important functional and social repercussions. Synkinesis is a frequent after-effect of facial palsy recovery, consisting of involuntary facial spasms that disturb the gestural harmony and can go as far as a painful hypertonic spasm. More than 55% of patients recovering from facial palsy will develop transient or permanent synkinesis. These facial hypertonias have two main causes: imperfect axonal regeneration, which is all the more important as the damage is proximal, and hyperexcitability of the facial nerve nucleus due to a lack of central control. Management is therefore essential for the functional restoration of the face, especially since synkinesis do not evolve spontaneously. The main treatments are currently botulinum toxin injection, acting on the motor plate, and functional rehabilitation, consisting on local muscle relaxation and central motor control work. In recent years, therapies based on biofeedback and acting on central motor control have shown interesting results, and technological advances in virtual reality have made it possible to deepen this treatment in patients suffering from stroke, limb trauma or Parkinson's disease. In this project, the investigators evaluate the contribution of virtual reality to the management of facial palsy, and hypothesize that self-rehabilitation using this technology will improve motor control of the skin muscles and reduce complications related to their hypertonia such as synkinesis.

Condition or Disease Intervention/Treatment Phase
  • Other: massages
  • Other: motor stimulation and stretching
  • Other: virtual reality
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis
Actual Study Start Date :
Sep 6, 2022
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental arm

patients benefiting from rehabilitation associated with virtual reality

Other: massages
The experimental rehabilitation protocol includes massages

Other: motor stimulation and stretching
motor stimulation and stretching

Other: virtual reality
Patient watches an avatar of his face performing different movements on a screen, and will have to imagine performing these movements without actually doing them.

Active Comparator: Control arm

patients benefiting from rehabilitation without virtual reality

Other: massages
The experimental rehabilitation protocol includes massages

Other: motor stimulation and stretching
motor stimulation and stretching

Outcome Measures

Primary Outcome Measures

  1. variation of number of involuntary facial spasm between both groups of patients [12 months]

    variation of synkinesis in patients with recent onset (≤ 12 months) peripheral facial palsy compared with the conventional rehabilitation protocol

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient with recent onset peripheral facial palsy (≤ 12 months).

  • Patient with peripheral facial palsy of grade ≥ III on the House & Brackmann score

  • Patient of legal age (≥ 18 years)

  • Patient with appropriate information and informed consent

Exclusion Criteria:
  • Patient with central facial palsy

  • Patient with peripheral facial palsy of > 12 months onset

  • Patient with peripheral facial palsy of grade < III House & Brackmann score

  • Patient who has previously undergone palliative surgery

  • Patient undergoing a botulinum toxin injection protocol

  • Patients benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection, pregnant or breast-feeding women and patients in emergency situations

  • Patients who have not provided informed consent

  • Patients with cognitive disorders that do not allow them to follow the proposed self-education protocol

  • Blind or visually impaired patients (visual acuity of the better eye after correction ≤ 4/10)

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Amiens Picardie Amiens Picardie France 80054

Sponsors and Collaborators

  • Centre Hospitalier Universitaire, Amiens
  • University Hospital, Rouen

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier:
NCT05547152
Other Study ID Numbers:
  • PI2019_843_0100
First Posted:
Sep 21, 2022
Last Update Posted:
Sep 21, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire, Amiens
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 21, 2022